Catamaran Corp (CTRX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Catamaran ( CTRX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.3%. By the end of trading, Catamaran fell $0.51 (-1.1%) to $44.47 on heavy volume. Throughout the day, 3,819,291 shares of Catamaran exchanged hands as compared to its average daily volume of 2,091,100 shares. The stock ranged in price between $44.22-$45.57 after having opened the day at $45.30 as compared to the previous trading day's close of $44.98. Other companies within the Health Services industry that declined today were: LipoScience ( LPDX), down 19.6%, Spherix ( SPEX), down 12.5%, Oculus Innovative ( OCLS), down 11.5% and Unilife Corporation ( UNIS), down 8.1%.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $9.3 billion and is part of the health care sector. Shares are down 5.2% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Catamaran a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front, ERBA Diagnostics ( ERB), up 6.8%, Cardica ( CRDC), up 5.2%, GenMark Diagnostics ( GNMK), up 4.5% and American Shared Hospital Services ( AMS), up 4.4% , were all gainers within the health services industry with Medtronic ( MDT) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists